Su-ann Yeoh
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Increased erythrocyte mean corpuscular volume by methotrexate predicts clinical response in psoriatic arthritis.
Journal: Rheumatology (Oxford, England)
Published: February 24, 2022
Experience with telemedicine among rheumatology clinicians during the COVID-19 pandemic: an international survey.
Journal: Rheumatology advances in practice
Published: January 18, 2022
The impact of COVID-19 on rheumatology training-results from the COVID-19 Global Rheumatology Alliance trainee survey.
Journal: Rheumatology advances in practice
Published: August 10, 2021
Rapid Adoption of Telemedicine in Rheumatology Care During the COVID-19 Pandemic Highlights Training and Supervision Concerns Among Rheumatology Trainees.
Journal: ACR open rheumatology
Published: May 23, 2021
Early reduction in circulating monocyte count predicts maintenance of remission in patients with rheumatoid arthritis treated with anti-TNF therapy.
Journal: Annals of the rheumatic diseases
Published: April 23, 2021
The synergistic efficacy of hydroxychloroquine with methotrexate is accompanied by increased erythrocyte mean corpuscular volume.
Journal: Rheumatology (Oxford, England)
Published: February 08, 2021
Patient and public involvement in rheumatology research: embracing the wave of change.
Journal: The Lancet. Rheumatology
Published: January 13, 2021
Lupus and the Lungs: The Assessment and Management of Pulmonary Manifestations of Systemic Lupus Erythematosus.
Journal: Frontiers in medicine
Published: September 25, 2020
Are treat-to-target and dose tapering strategies for rheumatoid arthritis possible during the COVID-19 pandemic?
Journal: The Lancet. Rheumatology
Published: August 25, 2020
An unfavourable outcome following switching intravenous abatacept and tocilizumab to subcutaneous forms during the COVID-19 pandemic.
Journal: Rheumatology (Oxford, England)
Published: August 02, 2020
Methotrexate reduces withdrawal rates of TNF inhibitors due to ineffectiveness in rheumatoid arthritis but only in patients who are seropositive.
Journal: Annals of the rheumatic diseases
Published: April 23, 2020
Last Updated: 09/26/2026